Chantix's Boxed Warning: Will A Positive Vote Justify A Negative Outcome?

FDA could use advisory committee members' comments to maintain the smoking cessation drug's boxed warning, even though they voted to remove it.

smoking cigarette in the hand of young man close up

Despite its recommendation to remove the boxed warning from the label of Pfizer Inc.'s smoking cessation product Chantix, advisory committee members still may have provided FDA the ammunition to make the opposite decision. The agency has had fair bit of time to mull the issue following the panel meeting in September since the user fee date is not until this month.

They levied many reservations and concerns about the data in the EAGLES trial, which Pfizer argued confirms that Chantix (varenicline)...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA Performance Tracker

More from Regulatory Trackers